Antibody-drug conjugates (ADCs) are new chemotherapeutic agents that can cause significant ocular side effects. Drs. Meghan Berkenstock, Lauren Dalvin, and Stella Kim review this new class of drugs and how they can affect the eye, providing essential tips for what to look for, when to screen, and how to treat the side effects. Prescribing information mentioned in this episode: Elahere (mirvetuximab soravtansine-gynx) Tivdak (tisotumab vedotin-tftv)
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
